Archive for September, 2008
THE ESTATE OF HENRY BROWNELL WILL LEAD A 450-LOT MULTI-ESTATE AUCTION PLANNED FOR OCTOBER 18 BY FONTAINE’S AUCTION GALLERY
(Pittsfield, Mass.) – A splendid period Queen Anne lowboy, made around 1750 in New Hampshire and with front ball-and-claw feet and the original brass hardware, is the expected headliner at a multi-estate sale slated for Saturday, Oct. 18, by Fontaine’s Auction Gallery. The lowboy, showing great proportions at 31-1/2 inches tall by 31-1/2 inches wide, […]
World Records Set at Skinner Fine Wine Sale
BOLTON, Mass. – September 30, 2008 – www.skinnerinc.com – Skinner, one of the nation’s leading auction houses for antiques and fine art, today announced it has set several world records for some of the most expensive bottles of fine wine sold at auction. At the recent Boston sale of Fine Wines, held September 19, 2008, […]
Part II of the Historic Alschuler Antique Paperweight Collection Expected to Set Records at Auction
L. H. Selman Ltd., premier antique paperweight dealer, is gearing up for its forty-second semi-annual paperweight auction. “Due to the overwhelming response to the Alschuler Auction Part I, we anticipate another exceptional sale this fall,” says Larry Selman. The second half of the Sam and Winifred Alschuler collection includes many of the most important paperweights […]
Ketterer Kunst to auction rare letter documenting the first circumnavigation of the globe
Hamburg (kk) – For € 80 000 it could be yours: the first empirical proof that the earth is round. The extremely rare original edition of a letter from Maximilianus Transsylvanus, secretary to the Holy Roman Emperor Charles V, is to go under the hammer at the Ketterer Kunst auction of Rare Books – Manuscripts […]
Spherics, Inc. Assignee Announces Strong Interest in Sealed Bid Auction in Spherics Intellectual Property
WELLESLEY HILLS, Mass., – Joseph F. Finn, Jr., C.P.A. (“Finn”), Assignee of the assets of Spherics, Inc. (“Spherics”) for the benefit of creditors, said, in an interview today, that interest in the Company’s therapeutic drugs and technology platforms was strong. Numerous confidential agreements have been signed and conference calls between the Company’s science team and […]
